Brief: Amgen Responds To FTC Action On Proposed Acquisition Of Horizon Therapeutics
16/05/2023 16:34
May 16 (Reuters) - Amgen Inc AMGN.O :
* AMGEN RESPONDS TO FTC ACTION RE: PROPOSED ACQUISITION OF
HORIZON
THERAPEUTICS
* AMGEN INC - INTEND TO WORK WITH COURT ON A SCHEDULE THAT
WOULD
ALLOW TRANSACTION TO CLOSE BY MID-DECEMBER
* AMGEN INC - REMAINS COMMITTED TO COMPLETING ACQUISITION
OF
HORIZON THERAPEUTICS PLC
Source text for Eikon: ID:nPn7G7DwLa
Further company coverage: AMGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Horizon Therapeutics
See all newsDeals of the day-Mergers and acquisitions
Amgen completes $27.8 bln Horizon deal (updated)
Amgen completes acquisition of Horizon Therapeutics
Brief: Amgen Completes Acquisition Of Horizon Therapeutics PLC
On October 5, Court Sanctioned The Scheme Of Arrangement Under Chapter 1 Of Part 9 Of The Irish Companies Act 2014